Early-Life Exposure to PFAS Linked to Bone Development in Adolescence

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on March 20, 2026.

via HealthDay

FRIDAY, March 20, 2026 -- Exposure to per- and polyfluoroalkyl substances (PFAS) in early life may influence bone development during adolescence, according a study published online March 17 in the Journal of the Endocrine Society.

Jessie P. Buckley, Ph.D., M.P.H., from the University of North Carolina at Chapel Hill, and colleagues examined the associations of repeated serum PFAS concentrations with early adolescent BMD among 218 children in a prospective pregnancy and birth cohort. Serum concentrations of perfluorohexane sulfonic acid (PFHxS), perfluoroctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), and perfluorononanoic acid (PFNA) were quantified at delivery and at ages 3, 8, and 12 years. Dual X-ray absorptiometry was used to measure BMD at six skeletal sites at age 12 years.

The researchers observed associations for higher PFOA concentrations with lower one-third distal radius BMD at every time point (β: −0.39, −0.36, −0.54, and −0.40 at delivery and ages 3, 8, and 12 years, respectively). Significant associations were seen for higher three-year PFHxS and PFOS concentrations with higher whole-body, total hip, and femoral neck BMD z-scores, while associations were seen for higher 12-year PFNA concentrations with lower BMD z-scores. Compared with boys, girls had stronger associations of 12-year PFAS with lower one-third distal radius BMD.

"Adolescence is a key period for building strong bones, and achieving optimal bone mass during this time can reduce lifelong risks of fractures and osteoporosis," Buckley said in a statement. "Our findings suggest reducing PFAS exposure during key developmental windows could support healthier bones throughout life."

Two authors served as expert witnesses in litigation, one of whom was financially compensated.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-21 01:42

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Early-Life Exposure to PFAS Linked to Bone Development in Adolescence

Read more

Disclaimer

Popular Keywords